Hmm, not sure what a "too large position" for MSB is! I am not even sure such a thing exists if you are patient and can wait for the building-up potential to finally burst free and the paradigm to finally shift. I believe in the science wholeheartedly, those clinical trials do NOT lie, so sinking a ton of cash into this company was a decision I made very coolly and logically.
Given that, I am confident that Rem-L will be approved by the FDA EVENTUALLY. So even if the FDA screws MSB tomorrow by rejecting the application, that "mistake" will be corrected eventually, the hit to the SP will be temporary, and upcoming trial results (and eventual Rem-L approval for AGVHD) will undo any "damage" done on 30 September by the FDA.
(20min delay)